Rupus Global Limited, the Hong kong based pharmaceutical Company today announced the induction of noted & eminent global researchers as advisors to the board of directors. Prof. Solomon Darwin, Director, UC Berkeley-Haas Center for Corporate Innovation, Executive Director, Center for Growth Markets & Dr. Satya Brahma, author columnist & founder chairman of Network 7 Media Group will be guiding & advising the Rupus Global Board of Directors in building Rupus as a strong international pharmaceutical company in its pursuit to its mission to widen its academic excellence. Rupus Global is the fastest growing pharmaceutical company, committed to increase access to high-quality healthcare by developing, producing and marketing affordable generic drugs in Domestic as well as International Markets.
Headquartered at Hong Kong, Rupus Global Limited (rupusglobal.com), one of the fastest growing pharmaceutical company with leadership position in active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and provides contract research and manufacturing services (CRAMS) in key segments ... (more)
Rupus Global Limited, the Hong kong based pharmaceutical Company today announced the induction of noted and eminent global researchers as advisors to the board of directors. Prof. Solomon Darwin, Director, UC Berkeley-Haas Center for Corporate Innovation, Executive Director, Center for Growth ... (more)
